# Anupam Rasayan will acquire up to 74.2% stake in Bliss GVS Pharma.

*biotech · news · 2026-05-23 · CNBC TV18*

## Key points

- Anupam Rasayan will acquire up to 74.2% stake in Bliss GVS Pharma.
- The acquisition involves a ₹1,369 crore investment at ₹299 per share for a 43.3% stake.
- Anupam Rasayan will launch an open offer for an additional 26% of Bliss GVS Pharma shares.
- The deal expands Anupam Rasayan into finished dosage formulations and integrated life sciences manufacturing.
- Acquisition funding combines a ₹300 crore term loan and non-controlling non-voting equity instruments.

**Companies:** Anupam Rasayan India Ltd, Bliss GVS Pharma Ltd
**Countries:** India, Africa, Asia, Latin America, United States, Europe

[Read the full story on CNBC TV18](https://www.cnbctv18.com/market/anupam-rasayan-enters-formulations-business-with-rs-1369-cr-bliss-gvs-pharma-acquisition-ws-l-19912112.htm)

---

Canonical: https://newsio.io/n/f65391a2-dfe5-4907-a8d8-86eb8278c805/anupam-rasayan-will-acquire-up-to-74-2-stake-in-bliss-gvs-pharma-deal-will-stren
Summarized by Newsio from CNBC TV18. https://newsio.io/how-it-works